HIV-associated neuropathies;HIV-assoziierte neuropathien

Nervenarzt

Volumn 81, Issue 4, 2010, Pages 409-417

  Hahn, K ^a   Husstedt, I W ^b   Arendt, G ^c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Diagnostics; HIV infection; Polyneuropathy; Polyradiculitis; Therapy

Indexed keywords

ACETYLCARNITINE; AMITRIPTYLINE; CANNABIS; CAPSAICIN; DAPSONE; DIDANOSINE; DOXORUBICIN; DULOXETINE; ETHAMBUTOL; GABAPENTIN; IMMUNOGLOBULIN; INDINAVIR; ISONIAZID; LAMOTRIGINE; LIDOCAINE; MEMANTINE; METRONIDAZOLE; MEXILETINE; MORPHINE; NAPROXEN; PREDNISOLONE; PREGABALIN; PROSAPOSIN; RITONAVIR; SAQUINAVIR; STAVUDINE; TRAMADOL; UNINDEXED DRUG; VINCRISTINE; ZALCITABINE;

AUTONOMIC NEUROPATHY; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL FEATURE; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DISTAL SYMMETRICAL POLYNEUROPATHY; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; ELECTROPHYSIOLOGY; GUILLAIN BARRE SYNDROME; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONONEUROPATHY MULTIPLEX; NERVE BIOPSY; OPPORTUNISTIC INFECTION; PATHOPHYSIOLOGY; PERIPHERAL NEUROPATHY; PLASMAPHERESIS; POLYNEUROPATHY; POLYRADICULONEUROPATHY; REVIEW; RISK FACTOR; SENSORY NEUROPATHY; SEROCONVERSION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; CROSS-SECTIONAL STUDIES; CYTOMEGALOVIRUS INFECTIONS; GUILLAIN-BARRE SYNDROME; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; POLYNEUROPATHIES; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING;

EID: 77953616177     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-010-2931-x     Document Type: Review

References (59)

1. Deutsche Neuro-AIDS-Arbeitsgemeinschaft DNAA (2000) Peripheral nerve diseases and myopathies associated with HIV infection. Nervenarzt 71:442-450
2. Abrams DI, Jay CA, Shade SB et al (2007) Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial. Neurology 68:515-521
3. Anders HJ, Weiss N, Bogner JR, Goebel FD (1998) Ganciclovir and foscarnet efficacy in AIDS-related CMV polyradiculopathy. J Infect 36:29-33
4. Apostolski S, McAlarney T, Quattrini A et al (1993) The gp120 glycoprotein of human immunodeficiency virus type 1 binds to sensory ganglion neurons. Ann Neurol 34:855-863
5. Apostolski S, McAlarney T, Hays AP, Latov N (1994) Complement dependent cytotoxicity of sensory ganglion neurons mediated by the gp120 glycoprotein of HIV-1. Immunol Invest 23:47-52
6. Bradley WG, Shapshak P, Delgado S et al (1998) Morphometric analysis of the peripheral neuropathy of AIDS. Muscle Nerve 21:1188-1195
7. Brannagan TH 3rd, Zhou Y (2003) HIV-associated Guillain-Barre syndrome. J Neurol Sci 208:39-42
8. Brinley FJ Jr., Pardo CA, Verma A (2001) Human immunodeficiency virus and the peripheral nervous system workshop. Arch Neurol 58:1561-1566
9. Cherry CL, Gahan ME, McArthur JC et al (2002) Exposure to dideoxynucleosides is reflected in lowered mitochondrial DNA in subcutaneous fat. J Acquir Immune Defic Syndr 30:271-277
10. Cornblath DR, McArthur JC, Kennedy PG et al (1987) Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type III infection. Ann Neurol 21:32-40
11. Craddock C, Pasvol G, Bull R et al (1987) Cardiorespiratory arrest and autonomic neuropathy in AIDS. Lancet 2:16-18
12. Dalakas MC, Semino-Mora C, Leon-Monzon M (2001) Mitochondrial alterations with mitochondrial DNA depletion in the nerves of AIDS patients with peripheral neuropathy induced by 2'3'-dideoxycytidine (ddC). Lab Invest 81:1537-1544
13. Esiri MM, Morris CS, Millard PR (1993) Sensory and sympathetic ganglia in HIV-1 infection: immunocytochemical demonstration of HIV-1 viral antigens, increased MHC class II antigen expression and mild reactive inflammation. J Neurol Sci 114:178-187
14. Estanislao L, Carter K, McArthur J et al (2004) A randomized controlled trial of 5% lidocaine gel for HIV-associated distal symmetric polyneuropathy. J Acquir Immune Defic Syndr 37:1584-1586
15. Evans SR, Simpson DM, Kitch DW et al (2007) A randomized trial evaluating prosaptide for HIV-associated sensory neuropathies: use of an electronic diary to record neuropathic pain. PLoS ONE 2:e551
16. Franco-Paredes C, Rebolledo P, Folch E et al (2002) Diagnosis of diffuse CD8+ lymphocytosis syndrome in HIV-infected patients. AIDS Read 12:408-413
17. Fuller GN, Gill SK, Guiloff RJ et al (1990) Ganciclovir for lumbosacral polyradiculopathy in AIDS. Lancet 335:48-49
18. Gherardi RK, Chretien F, Delfau-Larue MH et al (1998) Neuropathy in diffuse infiltrative lymphocytosis syndrome: an HIV neuropathy, not a lymphoma. Neurology 50:1041-1044
19. Griffin JW, Wesselingh SL, Griffin DE et al (1994) Peripheral nerve disorders in HIV infection. Similarities and contrasts with CNS disorders. Res Publ Assoc Res Nerv Ment Dis 72:159-182
20. Hahn K, Arendt G, Braun JS et al (2004) A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathies. J Neurol 251:1260-1266
21. Hahn K, Triolo A, Hauer P et al (2007) Impaired reinnervation in HIV infection following experimental denervation. Neurology 68:1251-1256
22. Hahn K, Robinson B, Anderson C et al (2008) Differential effects of HIV infected macrophages on dorsal root ganglia neurons and axons. Exp Neurol 210:30-40
23. Hulgan T, Haas DW, Haines JL et al (2005) Mitochondrial haplogroups and peripheral neuropathy during antiretroviral therapy: an adult AIDS clinical trials group study. AIDS 19:1341-1349
24. Itescu S, Brancato LJ, Winchester R (1989) A sicca syndrome in HIV infection: association with HLA-DR5 and CD8 lymphocytosis. Lancet 2:466-468
25. Jones G, Zhu Y, Silva C et al (2005) Peripheral nerve-derived HIV-1 is predominantly CCR5-dependent and causes neuronal degeneration and neuroinflammation. Virology 334:178-193
26. Katsarava Z, Yaldizli O, Voulkoudis C et al (2006) Pain related potentials by electrical stimulation of skin for detection of small-fiber neuropathy in HIV. J Neurol 253:1581-1584
27. Kazi S, Cohen PR, Williams F et al (1996) The diffuse infiltrative lymphocytosis syndrome. Clinical and immunogenetic features in 35 patients. AIDS 10:385-391
28. Keilbaugh SA, Prusoff WH, Simpson MV (1991) The PC12 cell as a model for studies of the mechanism of induction of peripheral neuropathy by anti-HIV-1 dideoxynucleoside analogs. Biochem Pharmacol 42:R5-R8
29. Keswani SC, Pardo CA, Cherry CL et al (2002) HIV-associated sensory neuropathies. AIDS 16:2105-2117
30. Keswani SC, Chander B, Hasan C et al (2003) FK506 is neuroprotective in a model of antiretroviral toxic neuropathy. Ann Neurol 53:57-64
31. Keswani SC, Polley M, Pardo CA et al (2003) Schwann cell chemokine receptors mediate HIV-1 gp120 toxicity to sensory neurons. Ann Neurol 54:287-296
32. Kieburtz K, Simpson D, Yiannoutsos C et al (1998) A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. AIDS clinical trial group 242 protocol team. Neurology 51:1682-1688
33. Lange DJ (1994) AAEM minimonograph #41: neuromuscular diseases associated with HIV-1 infection. Muscle Nerve 17:16-30
34. Lichtenstein KA, Armon C, Baron A et al (2005) Modification of the incidence of drug-associated symmetrical peripheral neuropathy by host and disease factors in the HIV outpatient study cohort. Clin Infect Dis 40:148-157
35. Lohmoller G, Matuschke A, Goebel FD (1989) False-positive test of autonomic neuropathy in HIV infection and AIDS? Case control study of heart rate variability in 62 HIV positive patients. Med Klin 84:242-245
36. Martin C, Solders G, Sonnerborg A, Hansson P (2000) Antiretroviral therapy may improve sensory function in HIV-infected patients: a pilot study. Neurology 54:2120-2127
37. McArthur JC, Brew BJ, Nath A (2005) Neurological complications of HIV infection. Lancet Neurol 4:543-555
38. Medina DJ, Tsai CH, Hsiung GD, Cheng YC (1994) Comparison of mitochondrial morphology, mitochondrial DNA content, and cell viability in cultured cells treated with three anti-human immunodeficiency virus dideoxynucleosides. Antimicrob Agents Chemother 38:1824-1828
39. Melli GaHA (2005) In vitro models of HIV-associated neuropathies differ in pathogenic site of action. 12th conference on retroviruses and opportunistic infections
40. Miller RG, Storey JR, Greco CM (1990) Ganciclovir in the treatment of progressive AIDS-related polyradiculopathy. Neurology 40:569-574
41. Morgello S, Estanislao L, Simpson D et al (2004) HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy: the Manhattan HIV Brain Bank. Arch Neurol 61:546-551
42. Moulignier A, Authier FJ, Baudrimont M et al (1997) Peripheral neuropathy in human immunodeficiency virus-infected patients with the diffuse infiltrative lymphocytosis syndrome. Ann Neurol 41:438-445
43. Paice JA, Ferrans CE, Lashley FR et al (2000) Topical capsaicin in the management of HIV-associated peripheral neuropathy. J Pain Symptom Manage 19:45-52
44. Pardo CA, McArthur JC, Griffin JW (2001) HIV neuropathy: insights in the pathology of HIV peripheral nerve disease. J Peripher Nerv Syst 6:21-27
45. Pettersen JA, Jones G, Worthington C et al (2006) Sensory neuropathy in human immunodeficiency virus/acquired immunodeficiency syndrome patients: protease inhibitor-mediated neurotoxicity. Ann Neurol 59:816-824
46. Polydefkis M, Yiannoutsos CT, Cohen BA et al (2002) Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathy. Neurology 58:115-119
47. Sacktor N (2002) The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. J Neurovirol 8 [Suppl 2]:115-121
48. Schielke E, Pfister HW, Einhaupl KM (1989) Peripheral facial nerve palsy associated with HIV infection. Lancet 1:553-554
49. Schifitto G, McDermott MP, McArthur JC et al (2002) Incidence of and risk factors for HIV-associated distal sensory polyneuropathy. Neurology 58:1764-1768
50. Schifitto G, McDermott MP, McArthur JC et al (2005) Markers of immune activation and viral load in HIV-associated sensory neuropathy. Neurology 64:842-848
51. Schifitto G, Yiannoutsos CT, Simpson DM et al (2006) A placebo-controlled study of memantine for the treatment of human immunodeficiency virus-associated sensory neuropathy. J Neurovirol 12:328-331
52. Simpson DM, Dorfman D, Olney RK et al (1996) Peptide T in the treatment of painful distal neuropathy associated with AIDS: results of a placebo-controlled trial. The Peptide T Neuropathy Study Group. Neurology 47:1254-1259
53. Simpson DM, McArthur JC, Olney R et al (2003) Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trial. Neurology 60:1508-1514
54. Tagliati M, Grinnell J, Godbold J, Simpson DM (1999) Peripheral nerve function in HIV infection: clinical, electrophysiologic and laboratory findings. Arch Neurol 56:84-89
55. Thornton CA, Latif AS, Emmanuel JC (1991) Guillain-Barre syndrome associated with human immunodeficiency virus infection in Zimbabwe. Neurology 41:812-815
56. Verma A (2001) Epidemiology and clinical features of HIV-1 associated neuropathies. J Peripher Nerv Syst 6:8-13
57. Wernicke JF, Pritchett YL, D'Souza DN et al (2006) A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology 67:1411-1420
58. Wulff EA, Wang AK, Simpson DM (2000) HIV-associated peripheral neuropathy: epidemiology, pathophysiology and treatment. Drugs 59:1251-1260
59. Youle M, Osio M (2007) A double-blind, parallel-group, placebo-controlled, multicentre study of acetyl L-carnitine in the symptomatic treatment of antiretroviral toxic neuropathy in patients with HIV-1 infection. HIV Med 8:241-250